This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maor, G. Articles by Karnieli, E. Search for Related Content PubMed PubMed Citation Articles by Maor, G. Articles by Karnieli, E.

The Insulin-Sensitive Glucose Transporter (GLUT4) Is Involved in Early Bone Growth in Control and Diabetic Mice, But Is Regulated through the Insulin-Like Growth Factor I Receptor¹

Departments of Morphological Sciences (G.M.) and Endocrinology (E.K.), The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology; and Institute of Endocrinology, Diabetes and Metabolism (E.K.), Rambam Medical Center, 31096 Haifa, Israel

Address all correspondence and requests for reprints to: Dr. Eddy Karnieli, Institute of Endocrinology, Diabetes and Metabolism, Rambam Medical Center, P.O. Box 9602, 31096 Haifa, Israel. E-mail: eddy{at}rambam.health.gov.il

Children with uncontrolled type I (insulin-dependent) diabetes mellitus are characterized by a slow growth rate, which improves upon adequate therapy. While skeletal growth is an energy-consuming process involving high glucose utilization, the role of glucose transporters (GLUT) and their regulation in the bone formation process are not yet fully understood. Thus, we studied both in vivo and in vitro early endochondral bone formation in control and streptozotocin-induced young diabetic mice. Using in situ hybridization and immunohistochemistry techniques, we demonstrated the novel existence of the insulin-sensitive glucose transporter (GLUT4), as well as GLUT1, in juvenile-derived murine mandibular condyles and in the humeral growth plate—two models for endochondral bone formation. Insulin-like growth factor (IGF) I receptors (IGF-I-R), but not insulin receptors (IR), were shown to have cellular distribution similar to GLUT4, being more abundant in mature chondrocytes. Further, in the skeletal growth centers of streptozotocin-induced diabetic mice, GLUT4, IGF-I, and IGF-I and insulin receptor levels, but not GLUT1, were markedly reduced. The decrease in GLUT4 and in IGF-I and insulin receptors was associated with severe histological changes in the mandibular condyles and humeral growth plate. Insulin therapy restored IR levels to normalcy, whereas IGF-I-R and GLUT4 levels were only partially recovered. Thus, GLUT4 and IGF-I-R have a potential role in early bone growth in mice. Further, during early bone growth GLUT4 may be regulated through the IGF-I receptor rather than via the insulin receptor. We propose that skeletal growth retardation in type I diabetes may be associated with reduced expression of the GLUT4 and IGF-I receptor in the bone growth center.

This article has been cited by other articles:

				E. Karnieli and M. Armoni Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E38 - E45. [Abstract] [Full Text] [PDF]

				K. M. Thrailkill, C. K. Lumpkin Jr., R. C. Bunn, S. F. Kemp, and J. L. Fowlkes Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E735 - E745. [Abstract] [Full Text] [PDF]

				R. Hokanson, S. Miller, M. Hennessey, M. Flesher, W. Hanneman, and D. Busbee Disruption of estrogen-regulated gene expression by dioxin: downregulation of a gene associated with the onset of non-insulin-dependent diabetes mellitus (type 2 diabetes) Human and Experimental Toxicology, December 1, 2004; 23(12): 555 - 564. [Abstract] [PDF]

				F. Schwartzenberg-Bar-Yoseph, M. Armoni, and E. Karnieli The Tumor Suppressor p53 Down-Regulates Glucose Transporters GLUT1 and GLUT4 Gene Expression Cancer Res., April 1, 2004; 64(7): 2627 - 2633. [Abstract] [Full Text] [PDF]

				X. Guan, J. J. Matte, P. K. Ku, J. L. Snow, J. L. Burton, and N. L. Trottier High Chromium Yeast Supplementation Improves Glucose Tolerance in Pigs by Decreasing Hepatic Extraction of Insulin J. Nutr., May 1, 2000; 130(5): 1274 - 1279. [Abstract] [Full Text]

				L. E. Levitt Katz, R. J. Ferry Jr., C. A. Stanley, P. F. Collett-Solberg, L. Baker, and P. Cohen Suppression of Insulin Oversecretion by Subcutaneous Recombinant Human Insulin-Like Growth Factor I in Children with Congenital Hyperinsulinism Due to Defective {beta}-Cell Sulfonylurea Receptor J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3117 - 3124. [Abstract] [Full Text]

				G. Pelletier, V. Luu–The, B. Têtu, and F. Labrie Immunocytochemical Localization of Type 5 17ß-Hydroxysteroid Dehydrogenase in Human Reproductive Tissues J. Histochem. Cytochem., June 1, 1999; 47(6): 731 - 738. [Abstract] [Full Text]